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Abstract: Barrett’s esophagus (BE) is associated with the development of esophageal adenocarcinoma (EAC). Bile 
acids (BAs) refluxing into the esophagus contribute to esophageal injury, which results in BE and subsequent EAC. 
We developed two animal models to test the role of BAs in the pathogenesis of BE. We surgically generated BA 
reflux, with or without gastric acid, in rats. In a second experiment, we fed animals separately with BAs and gastric 
acid. Pathologic changes were examined and the expression of Muc2 and Cdx2 in BE tissue was tested by immu-
nostaining. Inflammatory factors in the plasma, as well as differentiation genes in BE were examined through highly 
sensitive ELISA and semi-quantitative RT–PCR techniques. We found that BAs are sufficient for the induction of 
esophagitis and Barrett’s-like metaplasia in the esophagus. Overexpression of inflammatory cells, IL-6, and TNF-α 
was observed both in animals fed with BAs and surgically generated BA reflux. Furthermore, elevated levels of Cdx2, 
Muc2, Bmp4, Kit19, and Tff2 (differentiation genes in BE) were found in BA-treated rats. In conclusion, BAs, but 
not gastric acid, are a major causative factor for BE. We confirmed that BAs contribute to the development of BE by 
inducing the inflammatory response in the esophagus. Inhibiting BAs may be a promising therapy for BE.
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Introduction
Esophageal adenocarcinoma (EAC) has been 
linked to chronic inflammation with an inci-
dence that has increased by greater than 500% 
[1]. The primary risk factor for EAC is Barrett’s 
Esophagus (BE), which invokes dysplastic pro-
gression [2]. Although there is great interest in 
the process of EAC [3-5], little is known regard-
ing the pathogenesis of BE.
BE is defined as the replacement of squamous 
epithelium in the distal esophagus with meta-
plastic intestinal columnar epithelium [6]. Until 
now, the primary animal model used to study 
BE has been the rat, comprised of performing 
an esophagojejunostomy to induce gastroduo-
denal reflux [7, 8]. The observation that duode-
noesophageal reflux induces BE in rats points 
to the importance of refluxed contents in BE 
pathogenesis. Reflux injury to the esophagus 
results in chronic inflammation, oxidative str- 
ess, and DNA damage that may contribute to 
the metaplastic and dysplastic conversion of 
BE [9].
Several clinical and experimental studies have 
shown that reflux of bile acids (BAs) into the 
esophagus contributes to the induction of 
esophageal injury, BE, and EAC [10-13]. How- 
ever, the role of BAs and gastric acids due to 
gastroduodenal reflux has not been clearly 
studied. Here in, we aimed to utilize two models 
of Barrett’s-like metaplasia, involving animal 
surgery and feeding of exogenous chemicals, to 
provide insight into the pathogenesis of BE.
Methods
Animals and treatment procedures
Eight-week-old male Wister rats weighing 250-
280 g (obtained from Shandong University 
Laboratory Animal Center, Jinan, China) were 
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used in this study. All animal handling was car-
ried out by experienced biotechnicians. The 
rats were housed under standard laboratory 
conditions with a 12 h light–dark cycle with 
three animals per cage. Animals were fed com-
mercial rat chow with water provided ad libi-
tum, without exposure to carcinogens. They 
were allowed to acclimate at least 1 week prior 
to surgery. Animals were weighed on a weekly 
basis. Solid food was withdrawn the day prior to 
surgery and for 1 day after surgery. For the fol-
lowing 24 hours, rats were fed with 10% glu-
cose saline, and then with a regular diet. 
Experiment I: surgical model
In group A, 30 rats underwent an end-to-side 
esophagojejunostomy with gastrectomy, desi- 
gned to result in duodenoesophageal bile 
reflux. Briefly, premedication with diethyl ether 
was performed in a closed induction box prior 
to positioning on the operating table. A midline 
laparotomy was performed, during which the 
esophagus was transected at the esophago-
gastric junction and anastomosed end-to-side 
to the jejunum with a single-layer, interrupted 
7-0 prolene suture. Approximately 6-8 stitches 
were necessary to ensure adequate mucosa-
to-mucosa apposition. The stomach was res- 
ected and the proximal duodenum was sutured 
with plasma muscularis embedding. By this 
method, duodenoesophageal reflux (without 
gastric acid) was established. The abdomen 
was irrigated with ceftriaxone sodium (160 mg/
kg) prior to closure. Intraoperatively, a simple 
device containing diethyl ether was used to 
maintain depth of anesthesia. Immediately 
postoperatively, 2 mL of 10% glucose was 
administered subcutaneously.
In group B, 30 rats underwent side-to-side 
esophagogastrojejunostomy without gastrecto-
my. Briefly, after median laparotomy, the proxi-
mal jejunum was anastomosed in a side-to-side 
fashion with the distal esophagus for an anas-
tomotic diameter of 1 cm. A one-layer interrupt-
ed 7-0 prolene suture was used to perform the 
anastomosis. To avoid anastomotic bleeding, 
some gastric vessels required ligation. The 
remaining process was similar to that of group 
A. In this manner, duodenogastroesophageal 
reflux was induced.
Group C was the control group, in which ten rats 
underwent median laparotomy. After abdomi-
nal closure, these rats also received 2 mL of 
10% glucose subcutaneously.
Figure 1. Appearance of esophagus after 6 month of surgery. C/H show the gross appearance of the intact esopha-
gus. A/F and B/G display the apperance of that suffered from 6 months of reflux due to surgical procedues (A/F, 
duodenoesophageal reflux; B/G, duodenogastroesophageal reflux). Surgical group rats show abnormally dilated 
esophagus, and esophageal inner surface displays nodular patches (arrow in G) and ulcers (arrow in F). D/I and E/J 
show the esophagus of animals fed with exogenous chemicals (D/I, bile acids feeding; E/J, acidic water feeding). 
The mucosa of these two groups become thick and nodular patches occur (arrow in G).
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Figure 2. Histopathology of esophageal. The sham group A/C show the nomal squamous epithelium. Barrett’s epi-
thelium, B/D intestinal type mucosa is present and bound on either side by squamous epithelium. Arrows indicate 
goblet cells in metaplastic epithelium.
Figure 3. Representative results of Muc2 and Cdx2 immunohistochemical staining on esophageal specimens. A. 
Marked positive staining for Muc2 (brown) in the glandular component of BE (200 ×). B. Expression of Cdx2 (brown) 
in the nuclei of BE areas (200 ×).
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All three groups of rats were sacrificed 6 
months after surgery.
Experiment II: nonsurgical model 
Seventy male Wister rats were randomly divid-
ed into three groups (groups D, E, and F). In 
group D, 30 rats were fed with water and chow 
containing bile acids (0.3% DCA, pH 7.0). In 
group E, 30 rats were fed with chow and acidic 
water containing HCl (0.01 M HCl, pH 2.0) and 
a physiologic concentration of pepsin (0.5 mg/l 
HCl; HCl/P). Group F was the control group, in 
which ten rats were fed with chow and clean 
water. Animals were fed for 6 months and were 
sacrificed at the end of the experiment. 
Histologic examination
Animals were sacrificed under general anesthe-
sia and the thoracic and abdominal cavities 
were inspected. The esophagus was removed, 
fuged at 1000 g for 10 min at 4°C and the plas-
ma was stored at -80°C. Plasma levels of proin-
flammatory cytokines IL-6 and TNF-α were 
evaluated with a highly sensitive ELISA test 
(Quantikine HS, R&D Systems, Minneapolis, 
MN, USA).
Immunostaining for Muc2 and Cdx2
Immunostaining was performed on paraffin 
sections using a microwave-based antigen 
retrieval technique. The antibodies used in this 
study included Muc2 (1:400 dilution, Abcam, 
Cambridge, MA, USA) and Cdx2 (Biogenex, San 
Ramon, CA, USA). Sections were treated with 
an Envision+ DAB kit (Dako, Glostrup, Denmark), 
according to the manufacturer’s instructions.
Semi-quantitative RT-PCR
Semi-quantitative RT–PCR (sqRT-PCR) was per-
formed for selected genes. Briefly, 2 μg total 
Table 1. Histopathological findings after 6 months of surgery
Histopathologic Findings
Group A
(esophagoje 
junostomy)  
(n = 17 + 3)
Group B
(esophago-gas 
trojejunostomy)  
(n = 24 + 2)
Group C
(control)
(n = 10)
Hyperkeratosis 11 21 0
Squamous hyperplasia 9 17 0
Esophagitis 13+3 19 0
Ulceration 5 4 0
Barrett’s esophagus 10 (50%) 12 (46.1%) 0
Carcinoma 3 5 0
No obvious difference was found in the incidence of esophageal disease 
between group A and B.
Table 2. Histopathological findings of animals fed with exog-
enous chemicals
Histopathologic Findings
Group D
(Bile acid  
feeding) 
(n = 29)
Group E
(Acidic water  
feeding)  
(n = 30)
Group F
(control)
(n = 10)
Hyperkeratosis 18 15 0
Squamous hyperplasia 15 11 0
Esophagitis 20 9 0
Ulceration 3 2 0
Barrett’s esophagus 6 (21.4%) 0 0
Carcinoma 0 0 0
Single asterisk indicates significant difference in the incidence of esophagi-
tis between group D and E (x2 = 8.96, P < 0.01). Double asterisks indicate 
significant difference in the incidence of Barrett’s esophagus between 
group D and E (x2 = 4.83, P < 0.05).
opened longitudinally, examined mac-
roscopically, and divided into three 
parts. One portion was fixed in 10% 
neutral buffered formalin, paraffin 
embedded, and stained with hema-
toxylin and eosin (H&E). The other two 
parts were stored at -70°C for subse-
quent biochemical assays. The slides 
were separately reviewed by two 
experienced pathologists, without 
knowledge of treatment group assign-
ment. The esophagus was examined 
for the presence of hyperkeratosis, 
squamous hyperplasia, esophagitis, 
ulcerations, metaplasia, and carcino-
ma. Barrett’s-type mucosa was 
defined as intestinal-type mucosa 
with goblet cell metaplasia, bound on 
both proximal and distal ends by 
squamous mucosa. The slides were 
scored based upon the presence or 
absence of Barrett’s-type epithelium, 
hyperkeratosis, squamous hyperpla-
sia, esophagitis, ulcerations, and 
carcinoma.
Determination of plasma IL-6 protein 
and TNF-α levels
Immediately after experiment termi-
nation, blood samples were placed 
into EDTA-containing vials and used 
to determine plasma IL-6 and TNF-α 
concentrations. Blood was centri-
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RNA (n = 5 to 6) from the same samples used 
for histologic analysis was reverse transcribed 
using oligo-dT priming and SuperscriptII 
(Invitrogen, Carlsbad, CA, USA). First-strand 
complementary DNA was used as the template 
for real-time polymerase chain reaction analy-
sis with TaqMan master mix and primers for 
rMuc2, rCdx2, rBmp4, rKrt19, and rTff2 
(Applied Biosystems, Carlsbad, CA, USA). Tran- 
script levels, determined in two independent 
complementary DNA preparations, were calcu-
lated as described and expressed relative to 
beta-actin as the housekeeping gene.
Statistical analysis
Data are expressed as the mean ± standard 
error of the mean. For data regarding sqRT–
PCR, the comparison between groups was 
assessed by one-way ANOVA followed by 
Bonferroni’s test. For data regarding the histo-
logic analysis, the comparison was assessed 
by using the chi-squared test. Statistical analy-
ses were performed with GraphPad Prism 
(GraphPad, San Diego, CA, USA) software.
Results
Surgery induces esophagitis, BE, and neopla-
sia
To understand the pathogenesis of BE, we gen-
erated two groups of rats with esophageal 
reflux, duodenoesophageal reflux, and gastro-
duodenoesophageal reflux. Of the 60 operated 
animals, 14 (23.3%, ten from group A, four from 
group B) died prior to the end of the experi-
ment: 1 (7.1%, one from group A) due to an 
anesthetic accident; three (21.4%, all from 
group B) from anastomotic bleeding; seven 
(50%, six from group A, one from group B) due 
to late anastomotic stricturing; and three 
(21.4%, all from group A) from generalized 
weakness. Surviving rats had a poor general 
outcome: deplumation, anemia, and intracta-
ble vomiting. However, they all gained weight at 
the end of the experiment. There were no 
deaths in the sham-operated group. 
Experimental rats showed an abnormally dilat-
ed, markedly thickened esophagus in those 
with gastroduodenal reflux 6 months after sur-
gery, compared with age-matched sham rats. 
However, there was no difference in the thick-
ness of the BE among surgical groups (Figure 
1A, 1B). The epithelial surface contained longi-
tudinal folds extending along the lower two-
thirds of the esophagus. These findings repre-
sented gross evidence of severe esophagitis. 
Nodular lesions in the lower esophagus were 
observed in 33 of 46 rats in both surgical 
groups (Figure 1F, 1G, 1I, indicated by arrows). 
The nodular lesions were associated with carci-
noma and basal cell hyperplasia.
Based on previously described criteria, the 
major histopathologic changes in both surgical 
groups were inflammation (35 of 46) and pro-
Figure 4. The inflammatory cytokines in the plasma of rats were checked for IL-6 (A) and TNF-α (B). Both surgeries 
and compounds increased the plasma level of IL-6 and TNF-α. However, no obvious difference between group A and 
group B in IL-6 and TNF-α levels was observed. Meanwhile, more inflammatory cytokines were observed in group D 
than in group E. (*P < 0.05 data are represented as the mean ± SEM). 
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Figure 5. mRNA expression (RT-qPCR) of 
Muc2, Cdx2, Bmp4, Krt19, and Tff2 in 
the tissue of BA-treated rats and acidic 
acid-treated rats (*P < 0.05 data are 
represented as the mean ± SEM).
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found epithelial hypoplasia (26 of 46). Prolife- 
ration increased significantly in the basal com-
partment of the esophagus (Figure 2B, 2D). 
BE did not occur in control rats; however, 10 of 
20 (50%) rats from group A with duodeno-
esophageal reflux and 12 of 26 (46.2%) rats in 
group B with duodenogastroesophageal reflux 
developed columnar metaplasia with mucus 
producing (Muc2+) cells (Figure 3A), similar to 
human BE. Glandular metaplasia originated 
from the lower esophagus because all lesions 
were above the esophageal anastomosis and 
had an intact muscularis propria layer on histol-
ogy. A total of 15% (3/20) of duodenoesopha-
geal reflux rats and 12.5% (5/26) of duodeno-
gastroesophageal reflux rats developed HGD 
and EAC (Table 1). These lesions were grossly 
visible within the distal end of the esophagus. 
During this stepwise progression to BE, we 
observed an increased expression of Cdx2 in 
groups A and B, without positive Cdx2 staining 
in the sham group (Figure 3B).
Bile acids but not gastric acids induce the de-
velopment of Barrett-like metaplasia
BE and EAC have been attributed to gastric 
acid and/or BA reflux leading to chronic eso- 
phagitis. In our two surgical rat models of 
esophageal reflux, metaplasia and dysplasia 
appeared to be more dependent upon bile acid 
compared with gastric acid exposure; while 
both surgeries allowed BA reflux, reflux with a 
mixture of gastric acid did not worsen the 
pathologic changes of BE (X2 = 0.0565, P > 
0.05, Table 1). To examine the impact of gastric 
acid and BA separately, we compared the effect 
of BA and gastric acid by feeding animals with 
deoxycholic acid (DCA) or acidic water in experi-
ment II.
Seventy animals underwent the experiment (30 
each for groups D and E, ten for group F). Sixty-
nine (98.6%, 29 from group D, 30 from group E, 
ten from group F) rats survived at the end of the 
experiment. The remaining rat died from weight 
loss and generalized weakness. Histologic 
examination of the esophagus is shown in Table 
2.
Acidic water treated rats did not show evidence 
of Barrett’s-like metaplasia. However, BA treat-
ed rats showed moderate esophagitis with 
inflammatory infiltrates (Table 2; Figure 1D, 1I). 
A total of 20.7% (6/29) of BA-treated rats 
showed metaplastic changes with higher over-
all metaplasia scores (X2 = 4.83, P < 0.05, 
Table 2), indicating a significant induction by BA 
of Barrett’s-like metaplasia. None of the BA 
treated rats had microscopically visible tumors 
in the distal esophagus. These data suggest 
that BAs play a significant role in the pathogen-
esis of Barrett-like metaplasia; although, we did 
not use BA at a pH level of 2, and therefore can-
not rule out that gastric acid may also play a 
role in esophageal carcinogenesis.
Bile acids induce inflammation in BE
Previous studies of BE in animal models sug-
gest that BA-induced inflammation is crucial for 
the development of metaplasia [14]. BA treat-
ment results in an increase of inflammatory 
cells in the esophageal tissue (20/29, Table 2), 
but fewer inflammatory cells were found in the 
acid-treated group (9/30, X2 = 8.96, P < 0.01). 
The same increase of inflammation was shown 
in esophageal tissues from surgical rats. In 
addition, we observed elevated IL-6 and TNF-α 
levels in the plasma of BA-treated rats as well 
as our two surgical groups of reflux rats (Figure 
4). Consistent with other studies, we confirmed 
that BAs contribute to the development of BE 
by inducing the inflammatory response in the 
esophagus.
Bile acids induce differential gene expression 
in BE
Finally, we examined the expression of marked 
differentiation genes in BE. BA-treated rats har-
boring metaplasia and reflux rats showed ele-
vated levels of Cdx2 and Muc2, which are con-
sistent with immunostaining results (Figures 3, 
5). Bmp4, Kit19, and Tff2, which are known to 
be involved in cellular differentiation and prolif-
eration, were also associated with BA treat-
ment and/or BA reflux (Figure 5). These inc- 
reased gene levels were also confirmed in pre-
vious studies [14, 15].
Discussion
Using two surgical models of gastroesophageal 
reflux and rats treated with BAs, we demon-
strated that BAs in reflux is sufficient to induce 
esophagitis and Barrett’s-like metaplasia in the 
esophagus. However, gastric acid alone is not 
as effective in introducing BE as BAs. Immu- 
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nostaining and gene expression provided evi-
dence that our rat models closely resemble 
characteristics of BE. We conclude that Bar- 
rett’s-like metaplasia partly results from BA 
reflux.
Although lesions are induced by acid and pep-
sin in rabbit-mimicked human reflux esophagi-
tis, the fact that the degree of damage does not 
completely correlate with the amount of 
refluxed material, and a considerable number 
of patients do not achieve complete mucosal 
healing after treatment with antisecretory med-
ication, suggests other contributing mecha-
nisms in reflux Barrett’s-like metaplasia [16]. 
Mixed reflux has been shown to produce more 
Barrett’s metaplasia in the esophagus than 
pure acid reflux [12]. Several researchers also 
found similar results: rats exposed to acid 
reflux had smaller ulcers than those with mixed 
reflux [10, 17]. This is also supported by clinical 
observations that patients with BE experienced 
significantly prolonged episodes of alkaline 
reflux, rather than acid reflux with a high con-
tent of free bile acids [18]. It could also explain 
why Barrett’s esophagus carries an increased 
risk of malignant transformation, as prolonged 
exposure to bile acids has been demonstrated 
in this group of patients. It is also known that 
BAs can cause oxidative stress and DNA dam-
age, and can inhibit proliferation of esophageal 
epithelial cells [19, 20].
Our rat models exhibit a columnar-lined esoph-
agus but lack abundant goblet cells; however, it 
is increasingly recognized that BE does not 
require classical intestinal metaplasia to estab-
lish the diagnosis [21, 22]. Ten of 20 rats had 
macroscopic BE in the esophagojejunostomy 
group and 12 of 26 rats in the esophagogastro-
jejunostomy group. Moreover, six of 29 rats had 
microscopic metaplasia in the BA-treated group 
compared with none of 30 in the acidic water 
treated group. This may suggest either a delay 
in metaplasia development in the BA-treated 
group, or that other factors (e.g. oxidative 
stress) are involved in the pathogenesis of 
Barrett’s-like metaplasia. Further study is 
required to identify the exact effects of BAs on 
the progression of BE. 
EAC is one of the most rapidly increasing can-
cers in the United States and Europe [1, 23, 
24]. As EAC is known to be associated with 
GERD and BE [25-27], a major issue in the pre-
vention of this cancer is whether a window of 
opportunity exists between the diagnosis of 
reflux-related interstitial metaplasia and the 
development of adenocarcinoma. Unconjugated 
bile acids, which are increased in the reflux 
contents of patients with BE [28] and in pati- 
ents on a high fat diet [29], accelerated the 
development of BE and dysplasia. Unconjugated 
BAs can induce gene promoter demethylation, 
leading to the activation of IL-6, Cdx2, or Notch 
1 gene expression in esophageal cells [30, 31], 
a finding we can confirm in our BA-treated rats. 
With BA reflux and/or BA treatment in our rats, 
there were higher scorings of metaplasia and 
inflammation, pointing to the possible signifi-
cance of BAs in the development of BE. 
Inhibition or saturation of BAs to prevent BA 
exposure may be a useful treatment of BE or 
could elongate the window of opportunity.
In summary, based on the finding that surgical 
experiments and exogenous chemicals induced 
BE in rat models, we conclude that BAs are 
involved in the development of Barrett’s meta-
plasia. BAs, but not acidic acids, are a major 
causative factor for BE in our model and possi-
bly in humans; the prevention of BE by inhibit-
ing BAs requires further investigation.
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